Pharmaceutical Preparations · DE · CIK 1822791
Clene Inc. develops novel clean-surfaced nanotechnology therapeutics for diseases with high unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Mar 31, 2026: 1 insider bought $217K · 1 sold $1.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 67,991 | $4.88 | $332K |
| Mar 30, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 15,536 | $5.10 | $79K |
| Mar 27, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 17,470 | $4.75 | $83K |
| Mar 26, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 5,319 | $5.40 | $29K |
| Mar 25, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 7,098 | $5.50 | $39K |
| Mar 24, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 5,492 | $5.78 | $32K |
| Feb 3, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 5,559 | $4.10 | $23K |
| Feb 2, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 3,800 | $4.04 | $15K |
| Jan 30, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 5,686 | $4.13 | $23K |
| Jan 29, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 15,284 | $4.32 | $66K |
| Jan 28, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 8,717 | $4.91 | $43K |
| Jan 27, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 4,139 | $5.08 | $21K |
| Jan 26, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 6,418 | $5.02 | $32K |
| Jan 23, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 5,556 | $5.27 | $29K |
| Jan 22, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 12,665 | $5.32 | $67K |
| Jan 21, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 12,119 | $5.05 | $61K |
| Jan 20, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 12,432 | $4.80 | $60K |
| Jan 16, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 7,923 | $5.13 | $41K |
| Jan 15, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 12,563 | $5.10 | $64K |
| Jan 14, 2026 | Ugwumba ChidozieTenPercentOwner | Sell | 19,621 | $5.12 | $100K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.